Breast Cancer Trial

Bone-dominant, Metastatic

FDG PET to Assess Therapeutic Response in Patients with Bone-dominant Metastatic Breast Cancer (FEATURE)

 

Physician and Research Staff Educational Material

This material is intended for promotional use among health care professionals and is NOT intended for use as patient educational material.

Patient Educational Material

Participating sites should note that the Central Institutional Review Board (CIRB) has approved this material.

    • Study Summary for Patients: Study rationale, details regarding treatment, and a simplified schema in lay language to provide a more visual description of the trial to patients

Information and Assistance from the National Cancer Institute

    • Locations and other information
    • Trained information specialists at the NCI are available to answer cancer-related questions from patients, family members or friends, health care providers, and researchers. Visit the NCI’s Cancer Information Service webpage for contact instructions, including telephone, live chat, email, and mail.

Clinical Trials.gov ID: NCT04316117

Return to Home Page | Review Other Active Trials